BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

246 hedge funds and large institutions have $3.74B invested in Blueprint Medicines in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 84 increasing their positions, 91 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
246
Holders Change
-32
Holders Change %
-11.51%
% of All Funds
3.89%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
34
Increased
84
Reduced
91
Closed
64
Calls
$11.6M
Puts
$7.29M
Net Calls
+$4.34M
Net Calls Change
+$6.7M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$341M
2
CCM
2
Cadian Capital Management
New York
$123M
3
FCM
3
Farallon Capital Management
California
$86.7M
4
State Street
4
State Street
Massachusetts
$145M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$250M

Top Sellers

1
TCM
1
TimesSquare Capital Management
New York
$15.6M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$0
3
Marshall Wace
3
Marshall Wace
United Kingdom
$11.9M
4
APM
4
Avidity Partners Management
Texas
$18.6M
5
William Blair Investment Management
5
William Blair Investment Management
Illinois
$69.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$28.6M +$629K +9,854 +2%
Loomis, Sayles & Company
27
Loomis, Sayles & Company
Massachusetts
$28M +$3.76M +58,923 +16%
Citadel Advisors
28
Citadel Advisors
Florida
$27.8M +$21.6M +338,425 +351%
Franklin Resources
29
Franklin Resources
California
$26.4M -$446K -6,981 -2%
Fisher Asset Management
30
Fisher Asset Management
Washington
$25.4M -$142K -2,218 -0.6%
Bank of America
31
Bank of America
North Carolina
$23.5M +$5.21M +81,501 +29%
EAM
32
Eagle Asset Management
Florida
$22.8M -$1.76M -27,598 -7%
First Manhattan
33
First Manhattan
New York
$20.2M – – –
Goldman Sachs
34
Goldman Sachs
New York
$19.6M -$5.99M -93,695 -23%
APM
35
Avidity Partners Management
Texas
$18.6M -$45M -703,816 -71%
Assenagon Asset Management
36
Assenagon Asset Management
Luxembourg
$17.5M +$13.8M +216,374 +371%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$15.8M -$25.3M -395,996 -62%
DCM
38
DAFNA Capital Management
California
$15.7M +$2.51M +39,369 +19%
TCM
39
TimesSquare Capital Management
New York
$15.6M -$73M -1,143,431 -82%
UBS AM
40
UBS AM
Illinois
$15.3M +$343K +5,369 +2%
Nuveen Asset Management
41
Nuveen Asset Management
Illinois
$14.6M -$8.64M -135,898 -37%
NHAS
42
Novo Holdings A/S
Denmark
$14.5M +$1.95M +30,526 +15%
Morgan Stanley
43
Morgan Stanley
New York
$14.3M +$5.45M +85,298 +61%
Deutsche Bank
44
Deutsche Bank
Germany
$12.7M -$218K -3,418 -2%
CS
45
Candriam SCA
Luxembourg
$12.1M -$10.4M -162,802 -46%
NI
46
Nextech Invest
Switzerland
$12M +$12M +188,228 New
Marshall Wace
47
Marshall Wace
United Kingdom
$11.9M -$48.8M -764,082 -80%
PAM
48
Panagora Asset Management
Massachusetts
$11.5M +$247K +3,867 +2%
SBH
49
Segall Bryant & Hamill
Illinois
$11.2M +$7.45M +116,602 +198%
EHI
50
Eagle Health Investments
Connecticut
$10.9M -$1.41M -22,088 -11%
1
2
3 4 5